Rampur Distillery Lights Up Diwali in Times Square New York City
1.11.2024 12:30:00 EET | Business Wire | Press release
Rampur Distillery celebrates Diwali 2024 with a striking display at Times Square, New York City.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030298390/en/
This #Diwali, we lit up Times Square with Rampur Indian Single Malt Asava - Best World Whisky! (Photo: Business Wire)
"Happy Diwali from all of us at Rampur Distillery! This festival symbolizes light, unity, and new beginnings. As we celebrate, we're proud to showcase our award-winning Rampur Indian Single Malt Whisky and introduce our Jugalbandi collection series, featuring Jugalbandi #5 and #6 expressions, set to launch in the United States in 2025. Times Square reflects our rich heritage and commitment to expanding our global presence. Together, let’s embrace the spirit of Diwali and look forward to a prosperous year ahead!" - Mr. Sanjeev Banga, President of International Business at Radico Khaitan.
In 2016, Rampur Distillery made a significant entry into the global whisky market with the launch of its flagship Rampur Select Indian Single Malt Whisky, quickly garnering attention for its rich flavor profile and exceptional craftsmanship.
As Diwali 2024 approaches, the distillery proudly celebrates its award-winning Rampur Asava, honored as the Best World Whisky 2023 by the John Barleycorn Awards. This accolade is a testament to Rampur's commitment to innovation and excellence in whisky-making.
Rampur Distillery has also expanded its luxury portfolio, offering a range of premium expressions crafted with meticulous attention to detail. Each expression showcases unique flavor profiles that reflect the artistry of Indian whisky-making. With the latest addition, Rampur Barrel Blush, the distillery continues to blend traditional techniques with modern influences, appealing to whisky enthusiasts and connoisseurs worldwide.
Mr. Kunal Madan, Vice President of International Business at Radico Khaitan, shares, “Happy Diwali! We are thrilled to celebrate this festive season with everyone. Alongside our award-winning products, we’re excited to share the news that we have recently launched Rampur Barrel Blush, our new expression that embodies the spirit of Diwali through its celebration of new beginnings and rich heritage. Just as Diwali signifies renewal and joy, this whisky invites you to share special moments with loved ones. Its intricate flavors complement the warmth of the season, making it a lovely choice to toast to prosperity and cherished memories. Cheers to family, festivities, and the joy of togetherness!”
Rampur Whisky offerings include:
- Rampur Select
- Rampur Double Cask
- Rampur Asava
- Rampur Barrel Blush
- Rampur Jugalbandi Series
- Sangam World Malt
View source version on businesswire.com: https://www.businesswire.com/news/home/20241030298390/en/
Contacts
exports@radico.co.in
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 02:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh
Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting26.3.2026 22:30:00 EET | Press release
Spring is in full swing at the “World’s Most Famous Building.” The Empire State Building (ESB) today announced a vibrant lineup of spring events in NYC, which include special experiences, treat pop-ups, and an iconic tower lighting that captures the joy and color of the beautiful season. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326216271/en/ Spring is in Full Bloom at the Empire State Building with New Festive Experiences, Sweet Treats, and Seasonal Tower Lighting “The Empire State Building Observation Deck has transformed into a celebration of the season and one of the best things to do in NYC this spring,” said Dan Rogoski, observatory general manager. “Whether it’s views beside our butterfly installation, sweet pop-ups, or a chance to spot the Easter Bunny, there is something special for every visitor.” Flutter of Color: The Empire State Building installed a brand-new photo opportunity on the 86th Floor Observati
Venture Global and Edison Announce Calcasieu Pass Arbitration Settlement26.3.2026 22:15:00 EET | Press release
Today, Venture Global and Edison jointly announced the signature of a commercial agreement for the settlement of the pending arbitration between the two companies concerning the Calcasieu Pass project. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326559130/en/ Completion of the settlement is expected by the end of Q2 2026, at which point the arbitration will be terminated. The agreement fully resolves the arbitration in its entirety. As part of the settlement, Edison and Venture Global have also agreed to the delivery to Europe of additional cargoes beyond those envisaged under the long-term contract, to support gas supplies primarily to the Italian market. The first delivery is scheduled for May 2026, in Italy, at the Adriatic LNG Terminal. The agreement represents a significant step in strengthening commercial cooperation between the parties and it establishes a foundation for further future deliveries in the context
Reply Recognized as a Microsoft Frontier Partner for Enterprise AI Delivery26.3.2026 20:06:00 EET | Press release
Reply [EXM, STAR: REY] announces it has been recognized as a Microsoft Frontier Partner within the Microsoft AI Cloud Partner Program, earning the Frontier Partner Badge for demonstrating advanced capabilities in delivering AI-first solutions across Cloud & AI Platforms, AI Business Solutions, and Security. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260326965586/en/ The recognition reflects Reply’s capabilities across the Microsoft ecosystem, built through the work of its specialized companies – including Aim Reply, Business Elements Reply, Cluster Reply, Root16 Reply, Solidsoft Reply, Valorem Reply, WM Reply and Zest Reply – supporting enterprise organizations in designing, implementing, and operating AI solutions on Microsoft platforms across real-world business scenarios. The Frontier Partner badge recognizes partners that demonstrate advanced AI driven capabilities and meet rigorous badge requirements at the time of
InterSystems nimittänyt terveydenhuoltotoiminnan johtajaksi tohtori Tim Ferrisin, entisen NHS- ja Mass General ‑johtajan26.3.2026 20:00:00 EET | Tiedote
InterSystems on luovien datateknologiaratkaisujen tarjoaja, jonka ratkaisuihin on tallennettu yli miljardi terveystietotietuetta maailmanlaajuisesti. Yritys ilmoitti tänään nimittäneensä terveydenhuoltotoiminnan johtajaksi lääketieteen tohtori Tim Ferrisin. Nimityksestä ilmoitettiin samaan aikaan, kun terveydenhuoltoalan johtajat kokoontuvat vuoden 2026 HIMSS Global Health Conference & Exhibition ‑tapahtumaan. Roolissaan Ferris pääsee soveltamaan kattavaa toimialakokemustaan, kun hän ohjaa yrityksen terveydenhuoltoratkaisujen kliinistä ja strategista suuntaa maailmanlaajuisesti. Laajan kokemuksensa turvin hän toimii maailmanlaajuisten terveydenhuoltojärjestelmien ja hallitusten strategisena neuvonantajana ja suunnittelee räätälöityjä teknologiaratkaisuja, jotka perustuvat todellisiin johtotason tarpeisiin. Samalla hän edistää akateemista tutkimustaan terveysdata-arkkitehtuurista sekä johtaa julkista keskustelua tekoälyn ja hoidon tarjoamisen yhdistämisestä. Ferris tuo InterSystemsiin a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom